Post [tmco]
Marketing [ocac]
surveillance [ftcn]
Acarbose [carb, phsu]
treatment [ftcn]
Patients [podg]
Diabetes Mellitus [dsyn]
Subject [grup]
Impaired glucose tolerance [dsyn]
China [geoa]
Objective [inpr]
Open [spco]
Study, Prospective [resa]
Interventional [topp]
surveillance [ftcn]
Conduct [inbe]
weeks [tmco]
Efficacy [qlco]
Safety [hcpp]
Acarbose [carb, phsu]
chinese [lang]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Subject [grup]
Impaired glucose tolerance [dsyn]
Routine [qlco]
practice [menp]
Subject [grup]
Impaired glucose tolerance [dsyn]
included [ftcn]
Acarbose [carb, phsu]
Approved [qlco]
treatment [ftcn]
condition [dsyn]
Patients [podg]
Methods [inpr]
Study Participant [grup]
Physicians [prog]
China [geoa]
Efficacy [qlco]
Parameters [fndg]
Initial [tmco]
Visit [bhvr]
End [spco]
Study [mnob]
Glycosylated haemoglobin [aapp, bacs]
HbA [aapp, bacs]
Fasting blood glucose [lbpr]
Postprandial [tmco]
Big [qnco]
Body Weight [orga]
majority [socb]
Study Participant [grup]
newly [idcn]
Diagnosed [fndg]
Administered [ftcn]
Acarbose [carb, phsu]
times [tmco]
Daily [tmco]
Recommended [idcn]
Standard [qlco]
Dose [qnco]
China [geoa]
Study [mnob]
Half [qnco]
Received [qlco]
Concomitant [tmco]
antihyperglycemic [phsu]
treatment [ftcn]
Acarbose [carb, phsu]
treatment [ftcn]
Reduced [qlco]
HbA [aapp, bacs]
Fasting blood glucose [lbpr]
mg dl [qnco]
mg dl [qnco]
2 hour [tmco]
Postprandial [tmco]
BG [gngm]
mg dl [qnco]
mg dl [qnco]
Body Weight [orga]
subgroup [virs]
Type 2 Diabetes [dsyn]
Impaired glucose tolerance [dsyn]
Conduct [inbe]
diabetic [fndg]
Patients [podg]
HbA [aapp, bacs]
Reduced [qlco]
Fasting blood glucose [lbpr]
mg dl [qnco]
2 hour [tmco]
Postprandial [tmco]
BG [gngm]
mg dl [qnco]
Marked [qlco]
reductions [npop]
Impaired glucose tolerance [dsyn]
HbA [aapp, bacs]
mg dl [qnco]
Fasting blood glucose [lbpr]
mg dl [qnco]
2 hour [tmco]
Postprandial [tmco]
BG [gngm]
baseline [bodm]
glucose levels [lbtr]
Group [idcn]
Patients [podg]
Type 2 Diabetes [dsyn]
Body Weight [orga]
Slightly [idcn]
Increased [qnco]
Impaired glucose tolerance [dsyn]
Acarbose [carb, phsu]
adverse events [fndg]
Serious [qlco]
Reported [inpr]
Attending physician [prog]
Assessed [acty]
Treatment Efficacy [qlco]
Good [qlco]
Very Good [inpr]
TOLERABILITY [resa]
Good [qlco]
Very Good [inpr]
Good [qlco]
Very Good [inpr]
Study Participant [grup]
Acarbose [carb, phsu]
Efficacy [qlco]
Well [qlco]
Accepted [qlco]
chinese [lang]
Patients [podg]
Type 2 Diabetes [dsyn]
Subject [grup]
Impaired glucose tolerance [dsyn]
treatment [ftcn]
condition [dsyn]
Combination [qlco]
antihyperglycemic [phsu]
Medication [phsu]
